Table 1.
Variables—Male | WISc | WISo3 | SHRc | SHRo3 |
BP (mmHg) | 111.74 ± 3.52 | 95.93 ± 4.47 * | 178.77 ± 3.83 * | 165.27 ± 3.98 |
BW (g) | 467.17 ± 17.95 | 428.17 ± 6.81 | 329.50 ± 8.37 * | 339.50 ± 6.69 |
HW (g) | 1.18 ± 0.04 | 1.13 ± 0.02 | 1.41 ± 0.03 * | 1.35 ± 0.04 |
LVW (g) | 0.81 ± 0.01 | 0.83 ± 0.02 | 1.16 ± 0.02 * | 1.12 ± 0.03 |
Variables—female | WISc | WISo3 | SHRc | SHRo3 |
BP (mmHg) | 101.18 ± 2.23 | 98.83 ± 2.91 | 187.33 ± 7.34 * | 172.83 ± 7.02 |
BW (g) | 266.83 ± 8.18 | 295.38 ± 10.05 | 213.00 ± 5.94 * | 216.33 ± 4.97 |
HW (g) | 0.83 ± 0.02 | 0.86 ± 0.02 | 1.31 ± 0.04 * | 1.13 ± 0.04 # |
LVW (g) | 0.59 ± 0.01 | 0.60 ± 0.01 | 1.01 ± 0.03 * | 0.92 ± 0.06 |
BP—Blood pressure; BW—body weight; HW—heart weight; LVW—left ventricular weight; WISc—wistar control rats; WISo3—WISc fed with omega-3; SHRc—spontaneously hypertensive rats; SHRo3—SHRc fed with omega-3. n = 16 in each group. Data are presented as means ± SEM; * p < 0.05 versus WISc; # p < 0.05 versus SHRs.